You can help save more lives

Today, 43 women in Australia will hear the life-changing words “You have breast cancer.”* 

Each of these women will face the heartbreaking task of telling their friends, their families and for some, their children. 

Sadly breast cancer is still the most common cancer in women in Australia. It is only through continued investment in research that we will be able to find a way to change the statistics for the women we love. 

With your support, the team of scientific and clinical researchers at Mater Research—our world-class research institute—are determined to find improved ways to diagnose, treat and ultimately prevent breast cancer. 

There are promising breast cancer projects happening right now at Mater—all thanks to your generosity. 

Trying to change the course of breast cancer treatment around the world 

Mater breast pathologist, Dr Cameron Snell, is doing research which could hold the key to improving treatment therapies for women with late stage breast cancer. 

Currently, all patients that have positive estrogen receptor forms of breast cancer—found in approximately 75 per cent of all breast cancer patients—are treated with hormonal therapy. However, only half of these patients will respond to this type of therapy. These women currently undergo the therapy, and its subsequent side effects, before waiting to see how their cancer responds. 

Dr Snell hopes to develop a test which will identify which women will respond positively to hormone therapy. This will enable clinicians to rapidly personalise treatment plans for each breast cancer patient. 

Dr Snell’s research is extremely promising and has the potential to change the course of breast cancer treatment for women not just at Mater, but around the world. 

You can help the women in your life affected by breast cancer. 

Please consider making a donation to Mater Chicks in Pink today and help fund this promising cancer research. 

Without your support, the breakthroughs that Mater researchers and clinicians are making would not be possible. The generous support of our donors is enabling Mater to make huge advances in cancer research—right in our own backyard.

Professor John Prins, Director and Chief Executive Officer—Mater Research.

*Source: Cancer Australia, 2016.